Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment

IntroductionTelemedical lifestyle programmes for people with type 2 diabetes mellitus (T2DM) provide an opportunity to develop a healthier lifestyle and consequently to improve health outcomes. When implementing new programmes into standard care, considering patients’ preferences may increase the success of the participants. This study aims to examine the preferences of people with T2DM with respect to telemedical lifestyle programmes, to analyse whether these preferences predict programme success and to explore the changes that may occur during a telemedical lifestyle intervention.Methods and analysisWe outline the protocol of the development and assessment of a discrete choice experiment (DCE) to examine patient preferences in a telemedical lifestyle programme with regard to the functions of the online portal, communication, responsibilities, group activities and time requirements. To develop the design of the DCE, we conducted pilot work involving healthcare experts and in particular people with T2DM using cognitive pretesting. The final DCE is being implemented within a randomised controlled trial for investigating whether participation in a telemedical lifestyle intervention programme sustainably improves the HbA1c values in 850 members of a large German statutory health insurance with T2DM. Preferences are being assessed before and after participants complete the programme. The DCE data will be analysed using regression and latent class analyses.Ethics and disseminationThe DCE study has been approved by the ethics committee of the medical faculty of the Heinrich Heine University Duesseldorf, registration number 2018-242-ProspDEuA, registered on 6 December 2018. The TeLIPro trial is registered at the US National Library of Medicine, registration number NCT03675919, registered on 15 September 2018. We aim to disseminate our results in peer-reviewed journals, at national and international conferences and among interested patient groups and the public.

Download Full-text

Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment

BMC Health Services Research ◽

10.1186/s12913-018-3484-0 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 10

Author(s):

Simon Fifer ◽

John Rose ◽

Kim K. Hamrosi ◽

Dan Swain

Keyword(s):

Type 2 Diabetes ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Choice Experiment ◽

Injection Frequency

Download Full-text

Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment

Value in Health ◽

10.1016/j.jval.2020.01.023 ◽

2020 ◽

Vol 23 (7) ◽

pp. 842-850 ◽

Cited By ~ 1

Author(s):

Semra Ozdemir ◽

Drishti Baid ◽

Naina R. Verghese ◽

Amanda YR. Lam ◽

Phong Ching Lee ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Patient Preferences ◽

Choice Experiment

Download Full-text

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

Diabetes Therapy ◽

10.1007/s13300-019-0591-9 ◽

2019 ◽

Vol 10 (2) ◽

pp. 735-749 ◽

Cited By ~ 5

Author(s):

Anne Brooks ◽

Jakob Langer ◽

Tommi Tervonen ◽

Mads Peter Hemmingsen ◽

Kosei Eguchi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Patient Preferences ◽

Choice Experiment ◽

Receptor Agonist

Download Full-text

Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey

Diabetes Therapy ◽

10.1007/s13300-017-0326-8 ◽

2017 ◽

Vol 8 (6) ◽

pp. 1365-1378 ◽

Cited By ~ 13

Author(s):

Carol Mansfield ◽

Mirko V. Sikirica ◽

Amy Pugh ◽

Christine M. Poulos ◽

Victoria Unmuessig ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Patient Preferences ◽

Choice Experiment

Download Full-text

A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1117433 ◽

2015 ◽

Vol 32 (2) ◽

pp. 251-262 ◽

Cited By ~ 26

Author(s):

A. Brett Hauber ◽

Hiep Nguyen ◽

Joshua Posner ◽

Iftekhar Kalsekar ◽

James Ruggles

Keyword(s):

Type 2 Diabetes ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Patient Preferences ◽

Choice Experiment ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Eating self-efficacy changes in individuals with type 2 diabetes following a structured lifestyle intervention based on the transcultural Diabetes Nutrition Algorithm (tDNA): A secondary analysis of a randomized controlled trial

PLoS ONE ◽

10.1371/journal.pone.0242487 ◽

2020 ◽

Vol 15 (11) ◽

pp. e0242487

Author(s):

Harvinder Kaur Gilcharan Singh ◽

Winnie Siew Swee Chee ◽

Osama Hamdy ◽

Jeffrey Ian Mechanick ◽

Verna Kar Mun Lee ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Weight Loss ◽

Motivational Interviewing ◽

Lifestyle Intervention ◽

Self Efficacy ◽

Controlled Trial ◽

Secondary Analysis ◽

Registration Number

Objective Eating self-efficacy behavior is an important predictor of successful lifestyle intervention. This secondary analysis evaluated the changes in eating self-efficacy behavior in patients with type 2 diabetes (T2D) and overweight/obesity following structured lifestyle intervention based on the Malaysian customized transcultural Diabetes Nutrition Algorithm (tDNA). Methods Patients with T2D and overweight/obesity (n = 230) were randomized either into the tDNA group which included a structured low-calorie meal plan using normal foods, incorporation of diabetes-specific meal replacements, and an exercise prescription or usual T2D care (UC) for 6 months. Patients in the tDNA group also received either counseling with motivational interviewing (tDNA-MI) or conventional counseling (tDNA-CC). The UC group received standard dietary and exercise advice using conventional counseling. Eating self-efficacy was assessed using a locally validated Weight Efficacy Lifestyle (WEL) questionnaire. All patients were followed up for additional 6 months’ post-intervention. Results There was a significant change in WEL scores with intervention over one-year [Group X Time effect: F = 51.4, df = (3.4, 318.7), p<0.001]. Compared to baseline, WEL scores improved in both the tDNA groups with significantly higher improvement in the tDNA-MI group compared to the tDNA-CC and UC groups at 6 months (tDNA-MI: 25.4±2.1 vs. tDNA-CC: 12.9±2.8 vs. UC: -6.9±1.9, p<0.001). At 12 months’ follow-up, both the tDNA groups maintained improvement in the WEL scores, with significantly higher scores in the tDNA-MI group than tDNA-CC group, and the UC group had decreased WEL scores (tDNA-MI: 28.9±3.1 vs. tDNA-CC: 11.6±3.6 vs. UC: -13.2±2.1, p<0.001). Patients in the tDNA-MI group with greater weight loss and hemoglobin A1C reduction also had a higher eating self-efficacy, with a similar trend observed in comparative groups. Conclusion Eating self-efficacy improved in patients with T2D and overweight/obesity who maintained their weight loss and glycemic control following a structured lifestyle intervention based on the Malaysian customized tDNA and the improvement was further enhanced with motivational interviewing. Clinical trial This randomized clinical trial was registered under National Medical Research Registry, Ministry of Health Malaysia with registration number: NMRR-14-1042-19455 and also under ClinicalTrials.gov with registration number: NCT03881540.

Download Full-text